 |
|
|
| |
Treatment-naïve, genotype-1 HCV-infected subjects show significantly greater HCV RNA decreases when treated with 28 days of ABT-333 plus peginterferon and ribavirin compared to peginterferon and ribavirin alone
|
| |
| |
Reported by Jules Levin
AASLD Nov 2 2009, Boston, MA
Maribel Rodriguez-Torres1, Eric Lawitz2, Daniel E. Cohen3,
Lois Larsen3, Rajeev M. Menon3, Christine Collins3,
Theresa Marsh3, Sara Gibbs3, and Barry Bernstein3
1. Fundacion de Investigacion de Diego, San Juan, Puerto Rico; 2. Alamo Medical Research, San Antonio, TX; 3. Abbott, Abbott Park, IL
|
| |
|
|
|
|
|
